They demonstrated that CAF-derived NLRP3/IL-1β facilitates tumor growth by recruiting myeloid-derived suppressor cells (MDSCs), thus altering the tumor microenvironment toward an immune-suppressive milieu.126 They further showed that tumor growth is delayed when NLRP3 or IL-1β is ablated. The gene discussed is IL1B; the disease is neoplasm.